Literature DB >> 14524628

Retrospective analysis of etiologic agents associated with respiratory diseases in pigs.

Young Ki Choi1, Sagar M Goyal, Han Soo Joo.   

Abstract

Twenty-eight hundred and seventy-two cases of respiratory disease in pigs were analyzed for their etiologic agents. Two or more pathogens were detected from 88.2% of the cases, indicating that porcine reproductive and respiratory syndrome virus (PRRSV) or swine influenza virus (SIV) combined with other bacterial agents was a common cause for porcine respiratory diseases in the mid-western USA.

Entities:  

Mesh：

Year:  2003        PMID： 14524628      PMCID： PMC340270     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  8 in total

1.  Application of a nested polymerase chain reaction assay to detect Mycoplasma hyopneumoniae from nasal swabs.

Authors:  M Calsamiglia; C Pijoan; A Trigo
Journal:  J Vet Diagn Invest       Date:  1999-05       Impact factor: 1.279

2.  Effect of Mycoplasma hyopneumoniae infection on the development of Haemophilus pleuropneumoniae pneumonia in pigs.

Authors:  T Yagihashi; T Nunoya; T Mitui; M Tajima
Journal:  Nihon Juigaku Zasshi       Date:  1984-10

3.  Emergence of H3N2 reassortant influenza A viruses in North American pigs.

Authors:  N N Zhou; D A Senne; J S Landgraf; S L Swenson; G Erickson; K Rossow; L Liu; K J Yoon; S Krauss; R G Webster
Journal:  Vet Microbiol       Date:  2000-05-22       Impact factor: 3.293

4.  Experimental in utero inoculation of late-term swine fetuses with porcine circovirus type 2.

Authors:  Charles S Johnson; Han S Joo; Kochakorn Direksin; Kyoung-Jin Yoon; Young K Choi
Journal:  J Vet Diagn Invest       Date:  2002-11       Impact factor: 1.279

5.  Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia.

Authors:  E L Thacker; P G Halbur; R F Ross; R Thanawongnuwech; B J Thacker
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

6.  Pneumonia in pigs induced by intranasal challenge exposure with pseudorabies virus and Pasteurella multocida.

Authors:  M C Fuentes; C Pijoan
Journal:  Am J Vet Res       Date:  1987-10       Impact factor: 1.156

7.  Prevalence of swine influenza virus subtypes on swine farms in the United States.

Authors:  Y K Choi; S M Goyal; H S Joo
Journal:  Arch Virol       Date:  2002-06       Impact factor: 2.574

8.  Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study.

Authors:  K Van Reeth; H Nauwynck; M Pensaert
Journal:  Vet Microbiol       Date:  1996-02       Impact factor: 3.293
  8 in total
  33 in total

1.  Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans.

Authors:  Marie Borggren; Jens Nielsen; Karoline Bragstad; Ingrid Karlsson; Jesper S Krog; James A Williams; Anders Fomsgaard
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea.

Authors:  Jin-Young Shin; Min-Suk Song; Eun Ho Lee; Young-Min Lee; Seok-Yong Kim; Hyong Kyu Kim; Joong-Kook Choi; Chul-Joong Kim; Richard J Webby; Young-Ki Choi
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

3.  Infection of cesarean-derived colostrum-deprived pigs with porcine circovirus type 2 and Swine influenza virus.

Authors:  Huiling Wei; Stephen D Lenz; William G Van Alstine; Gregory W Stevenson; Ingeborg M Langohr; Roman M Pogranichniy
Journal:  Comp Med       Date:  2010-02       Impact factor: 0.982

4.  Efficacy of swine influenza A virus vaccines against an H3N2 virus variant.

Authors:  Jee Hoon Lee; Marie René Gramer; Han Soo Joo
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

5.  Innate immune response to a H3N2 subtype swine influenza virus in newborn porcine trachea cells, alveolar macrophages, and precision-cut lung slices.

Authors:  Mario Delgado-Ortega; Sandrine Melo; Darsaniya Punyadarsaniya; Christelle Ramé; Michel Olivier; Denis Soubieux; Daniel Marc; Gaëlle Simon; Georg Herrler; Mustapha Berri; Joëlle Dupont; François Meurens
Journal:  Vet Res       Date:  2014-04-09       Impact factor: 3.683

6.  Different clinical, virological, serological and tissue tropism outcomes of two new and one old Belgian type 1 subtype 1 porcine reproductive and respiratory virus (PRRSV) isolates.

Authors:  Ilias S Frydas; Ivan Trus; Lise K Kvisgaard; Caroline Bonckaert; Vishwanatha R A P Reddy; Yewei Li; Lars E Larsen; Hans J Nauwynck
Journal:  Vet Res       Date:  2015-03-21       Impact factor: 3.683

7.  Insights on the virulence of swine respiratory tract mycoplasmas through genome-scale metabolic modeling.

Authors:  Mariana G Ferrarini; Franciele M Siqueira; Scheila G Mucha; Tony L Palama; Élodie Jobard; Bénédicte Elena-Herrmann; Ana T R Vasconcelos; Florence Tardy; Irene S Schrank; Arnaldo Zaha; Marie-France Sagot
Journal:  BMC Genomics       Date:  2016-05-13       Impact factor: 3.969

8.  Actinobacillus pleuropneumoniae induces SJPL cell cycle arrest in G2/M-phase and inhibits porcine reproductive and respiratory syndrome virus replication.

Authors:  Jérémy A Ferreira Barbosa; Josée Labrie; Francis Beaudry; Carl A Gagnon; Mario Jacques
Journal:  Virol J       Date:  2015-11-14       Impact factor: 4.099

Review 9.  Medicinal plants--prophylactic and therapeutic options for gastrointestinal and respiratory diseases in calves and piglets? A systematic review.

Authors:  Hannah Ayrle; Meike Mevissen; Martin Kaske; Heiko Nathues; Niels Gruetzner; Matthias Melzig; Michael Walkenhorst
Journal:  BMC Vet Res       Date:  2016-06-06       Impact factor: 2.741

10.  Retrospective Analysis of Bacterial and Viral Co-Infections in Pneumocystis spp. Positive Lung Samples of Austrian Pigs with Pneumonia.

Authors:  Christiane Weissenbacher-Lang; Branislav Kureljušić; Nora Nedorost; Bettina Matula; Wolfgang Schießl; Daniela Stixenberger; Herbert Weissenböck
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.